Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational study
BMJ Open · 2025
DOI: 10.1136/bmjopen-2024-098317 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift BMJ Open, 2025. Verfasst von Megan Kurz und 18 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Methadone, Opiate Substitution Treatment, Opioid-Related Disorders, Analgesics, Opioid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDA NIH HHS, National Institutes on Drug Abuse.
Abstract (Originalsprache)
Introduction The introduction of fentanyl and its analogues in the illicit drug supply has prompted greater emphasis on refining clinical treatment protocols to ensure sustained retention in opioid agonist treatment (OAT). Take-home dosing may lessen the treatment burden on clients and thus reduce the risk of treatment discontinuation. The evidence base supporting the use of take-home dosing, including the optimal duration of dispensations, is, however, limited. The objective of this study is to determine the comparative effectiveness of alternative take-home dosing schedules, as observed in clinical practice in British Columbia, Canada from 2010 to 2022. Methods and analysis We propose to emulate a target trial with a population-level retrospective study of individuals initiating methadone or buprenorphine/naloxone between 1 January 2010 and 31 December 2022 who are 18 years of age or older and not currently incarcerated or pregnant with no history of cancer or palliative care. Our study will draw on nine linked health administrative databases from British Columbia and will evaluate take-home doses of 2–5 days, 6 days or >6 days compared with continuous daily dosing. The primary outcomes include OAT discontinuation and all-cause mortality on treatment. A causal per-protocol analysis is proposed with longitudinal matching and inverse probability of censoring weighting approaches to adjust for time-fixed and time-varying confounding. A range of sensitivity analyses will be executed to determine the robustness of results. Ethics and dissemination The protocol, cohort creation and analysis plan have been classified and approved as a quality improvement initiative by Providence Health Care Research Ethics Board and the Simon Fraser University Office of Research Ethics. Results will be disseminated and shared with local advocacy groups and decision-makers, developers of national and international clinical guidelines, presented at national and international conferences and published in peer-reviewed journals electronically and in print.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada.
- Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
- School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
- Département de médecine de famille et de médecine d'urgence, Université de Montréal, Montreal, Quebec, Canada.
- Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
- Children's Health Policy Centre, Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Förderung
- NIDA NIH HHS
- National Institutes on Drug Abuse
Zitieren
APA
Kurz, M., Guerra-Alejos, B. C., Hossain, M. B., Min, J. E., Yan, R., Bruneau, J., Catherine, N. L. A., Greenland, S., Gustafson, P., Hedden, L., Karim, E., McCandless, L., Nolan, S., Platt, R. W., Bach, P., Seaman, S., Siebert, U., Socías, M. E., & Nosyk, B. (2025). Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational study. BMJ Open. https://doi.org/10.1136/bmjopen-2024-098317
Vancouver
Kurz M, Guerra-Alejos BC, Hossain MB, Min JE, Yan R, Bruneau J, et al. Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational study. BMJ Open. 2025. doi:10.1136/bmjopen-2024-098317
BibTeX
@article{Kurz2025,
author = {Kurz, Megan and Guerra-Alejos, B Carolina and Hossain, Md Belal and Min, Jeong Eun and Yan, Ruyu and Bruneau, Julie and Catherine, Nicole L A and Greenland, Sander and Gustafson, Paul and Hedden, Lindsay and Karim, Ehsan and McCandless, Lawrence and Nolan, Seonaid and Platt, Robert W and Bach, Paxton and Seaman, Shaun and Siebert, U and Socías, M Eugenia and Nosyk, Bohdan},
title = {Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational study},
journal = {BMJ Open},
year = {2025},
doi = {10.1136/bmjopen-2024-098317}
}
EUVIMED